Resources

Past Presentation

Virtual Medications for Opioid Use Disorder (MOUD): Implementation, Outcomes and Lessons Learned | July 10, 2023

Date of Presentation: July 10, 2023

Type: Past Presentation  

Program: Virtual Care Implementation  

Keywords: #opiate use disorder  #OUD  #VCI  #virtual  #virtual care  

In this presentation, Dr. Bradley Buchheit MD, outlines the rapid transition of the Harm Reduction and Bridges to Care (HRBR) Clinic from in-person visits to 100% telemedicine during the COVID-19 Public Health Emergency. The talk will outline the current HRBR workflows, staffing, and scheduling. It will also highlight patient, peer and provider experiences with providing buprenorphine via telemedicine and the facilitators and barriers to implementing tele-buprenorphine.

 

 

Recording:

Presented by:

Bradley Buchheit, MD

Dr. Buchheit earned his medical degree from the State University of New York – University at Buffalo.  He completed a family medicine residency, addiction medicine fellowship and general preventive medicine and public health fellowship at Boston University/Boston Medical Center. He also completed a Master of Science degree in Health Services and Systems Research and has applied this knowledge to perform qualitative research related to substance use and substance use disorder treatments. He is triple board certified in Family Medicine, Addiction Medicine and General Preventive Medicine & Public Health.  Dr. Buchheit started his academic career in 2019 as a primary care doctor and addictionologist at Oregon Health & Science University (OHSU).  His responsibilities at OHSU include being the medical director of the Harm Reduction and BRidges to Care (HRBR) Clinic – a low barrier, on demand, addiction treatment clinic, serving as the program director for the addiction medicine fellowship, seeing patients with the Improving Addiction Care Team (IMPACT) – an in-patient addiction consult service, and seeing complex addiction medicine patient consults within an OHSU primary care practice.  His research interests include overdose prevention, how patients experience addiction treatment, and low-barrier buprenorphine. He is the treasurer for the Oregon Society of Addiction Medicine. 

Resources Provided:

Date added: July 7, 2023